(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Dr. Charles Bishop, CEO of OPKO Health Renal Division, to discuss the FDA’s approval of Rayaldee and the health issues surrounding chronic kidney disease

Lyft Earnings Miss Estimates After Global Expansion Push
25:56

Wall Street Poised for Bonus Increases in ‘Year of the Bank’
26:24

AMD Soars as AI Demand Fuels Better-Than-Expected Sales Outlook
20:33